These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 12678479
1. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Merlino JI, Ko K, Minotti A, McHenry CR. Am Surg; 2003 Mar; 69(3):225-9; discussion 229-30. PubMed ID: 12678479 [Abstract] [Full Text] [Related]
2. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Casas AT, Burke GJ, Mansberger AR, Wei JP. Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968 [Abstract] [Full Text] [Related]
3. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism. Billy HT, Rimkus DR, Hartzman S, Latimer RG. Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462 [Abstract] [Full Text] [Related]
4. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Casas AT, Burke GJ, Sathyanarayana, Mansberger AR, Wei JP. Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295 [Abstract] [Full Text] [Related]
5. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Casara D, Rubello D, Pelizzo MR, Shapiro B. Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294 [Abstract] [Full Text] [Related]
6. Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Goldstein RE, Carter WM, Fleming M, Bumpous J, Lentsch E, Rice M, Flynn M. Arch Surg; 2006 Jun; 141(6):552-7; discussion 557-9. PubMed ID: 16785355 [Abstract] [Full Text] [Related]
7. Cost utility of routine imaging with Tc-99m-sestamibi in primary hyperparathyroidism before initial surgery. Wei JP, Burke GJ. Am Surg; 1997 Dec; 63(12):1097-100; discussion 1100-1. PubMed ID: 9393259 [Abstract] [Full Text] [Related]
8. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Haber RS, Kim CK, Inabnet WB. Clin Endocrinol (Oxf); 2002 Aug; 57(2):241-9. PubMed ID: 12153604 [Abstract] [Full Text] [Related]
10. Value of sestamibi scans in tertiary hyperparathyroidism. Loftus KA, Anderson S, Mulloy AL, Terris DJ. Laryngoscope; 2007 Dec; 117(12):2135-8. PubMed ID: 17891049 [Abstract] [Full Text] [Related]
11. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Katz SC, Wang GJ, Kramer EL, Roses DF. Am Surg; 2003 Feb; 69(2):170-5. PubMed ID: 12641362 [Abstract] [Full Text] [Related]
12. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: what role in clinical practice? Carter WB, Sarfati MR, Fox KA, Patton DD. Am Surg; 1997 Apr; 63(4):317-21. PubMed ID: 9124749 [Abstract] [Full Text] [Related]
13. Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Berczi C, Mezõsi E, Galuska L, Varga J, Bajnok L, Lukács G, Balázs G. Eur Radiol; 2002 Mar; 12(3):605-9. PubMed ID: 11870476 [Abstract] [Full Text] [Related]
14. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism. Blanco I, Carril JM, Banzo I, Quirce R, Gutierrez C, Uriarte I, Montero A, Vallina NK. Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153 [Abstract] [Full Text] [Related]
15. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Goldstein RE, Billheimer D, Martin WH, Richards K. Ann Surg; 2003 May; 237(5):722-30; discussion 730-1. PubMed ID: 12724639 [Abstract] [Full Text] [Related]
16. The sestamibi scan as a preoperative screening tool. Norton KS, Johnson LW, Griffen FD, Burke J, Kennedy S, Aultman D, Li BD, Zibari G. Am Surg; 2002 Sep; 68(9):812-5. PubMed ID: 12356156 [Abstract] [Full Text] [Related]
17. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. Westerdahl J, Bergenfelz A. World J Surg; 2004 Nov; 28(11):1132-8. PubMed ID: 15490068 [Abstract] [Full Text] [Related]
18. Treatment with oral biphosphonates can increase the sensitivity of sestamibi radionuclide imaging in patients with primary hyperparathyroidism. Makras P, Kaltsas GA, Athanasoulis T, Papadogias D, Zografos GN, Kontogeorgos G, Borboli N, Piaditis G. Int J Clin Pharmacol Res; 2005 Nov; 25(1):19-28. PubMed ID: 15864874 [Abstract] [Full Text] [Related]
19. Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients. Jones JM, Russell CF, Ferguson WR, Laird JD. Clin Radiol; 2001 Jul; 56(7):556-9. PubMed ID: 11446753 [Abstract] [Full Text] [Related]
20. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. Parikshak M, Castillo ED, Conrad MF, Talpos GB. Am Surg; 2003 May; 69(5):393-8; discussion 399. PubMed ID: 12769210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]